Examination of the efficacy of ChemoCalc in the explanation of the breast cancer adjuvant treatment

Examination of the efficacy of ChemoCalc in the explanation of the breast cancer adjuvant treatment - Examination of the efficacy of ChemoCalc in the explanation of the breast cancer adjuvant treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030192

Enrollment

Registered

2017-12-01

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Using software of calculating drug costs Disuding software of calculating drug costs

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who planned initiation of the adjuvant postoperative treatment

Exclusion criteria

Exclusion criteria: Patients with dementia

Design outcomes

Primary

Measure	Time frame
Understanding about drug costs	—

Countries

Japan

Contacts

Public ContactSayaka Kuba

Nagasaki University Graduate School of Biomedical Science Surgery

skuba@nagasaki-u.ac.jp095-849-7316

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026